XXII

About XXII

22nd Century Group, Inc. is an agricultural biotechnology and intellectual property company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the consumer goods and pharmaceutical industries. The Company operates through two segments: Tobacco and Hemp/cannabis. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers’ branded filtered cigars and cigarettes. Its tobacco segment is engaged in the sale of its proprietary low nicotine content cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. Its Hemp/cannabis segment is engaged in developing cannabidiol (CBD) wholesale extracts and bulk ingredient distillate or isolate.